- Home
- GCTK
GCTK
GlucoTrack Inc.
as 06-27-2025 12:31pm EST
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | RUTHERFORD |
| Market Cap: | 4.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -566.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.16 - $3756.00 | Next Earning Date: | 08-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest GlucoTrack Inc. News
GCTK Breaking Stock News: Dive into GCTK Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Top Premarket Gainers
MT Newswires
4 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires
4 days ago
Top Midday Gainers
MT Newswires
4 days ago
Sector Update: Health Care Stocks Softer Wednesday Afternoon
MT Newswires
4 days ago
GlucoTrack Says its First Continuous Blood Glucose Monitor Human Trial Demonstrated 'Excellent Accuracy'
GlobeNewswire
4 days ago
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire
17 days ago
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
GlobeNewswire
25 days ago
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
Compare GCTK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GCTK GlucoTrack Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.